Effectiveness of Somatostatin Analogs versus Placebo for Graves Ophthalmopathy: A Meta-Analysis
|
|
- Willis Simon
- 5 years ago
- Views:
Transcription
1 Review Articles Chin J Evid-based Med 2013, 13(1): * Graves GO PubMed EMbase The Cochrane Library WanFang Data CNKI VIP CBM Graves RCT RevMan 5.0 Meta 5 RCT 210 Meta GO MD= %CI P=0.04 mmmd= %CI P=0.24 GO OR= %CI P=0.61 GO GO RCT Graves Meta Effectiveness of Somatostatin Analogs versus Placebo for Graves Ophthalmopathy: A Meta-Analysis SHI Shao-min, HE Ye-bing * Department of Endocrinology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan , China Abstract Objective To systematically evaluate the effectiveness of somatostatin analogs versus placebo for Graves ophthalmopathy (GO). Methods Such databases as PubMed, EMbase, The Cochrane Library, WanFang Data, CNKI, VIP and CBM were searched to collect the randomized controlled trails (RCTs) about somatostatin analogs for Graves Ophthalmopathy (GO) pulished by March 2012, while the bibliographies of the included literatue were also retrieved. According to the inclusion criteria, two reviewers screened literature, extracted data and assessed the quality of the included studies. Then meta-analysis was conducted using RevMan 5.0 software. Results A total of 5 RCTs involving 210 patients were included. The results of meta-analysis showed that somatostatin analogs could reduce the clinical activity score (CAS) of GO patients (MD=0.58, 95%CI 0.02 to1.13, P=0.04), but the effects in reducing the degree of proptosis (mm) was still unverifiable (MD=0.21, 95%CI 0.14 to 0.56, P=0.24). It did not show obvious effects for diplopia, orbital volume, intraocular pressure, visual acuity or the restriction of eye movements. The existing evidence could not confirm that somatostatin analogs were effective for GO (OR=1.32, 95%CI 0.45 to 3.9, P=0.61). Conclusion Somatostatin analogs can reduce the CAS of GO patients, but without significantly clinical significance. Moreover, the effect of reducing proptosis is sitll unverifiable. So the existing evidence cannot confirm that somatostatin analogs are effective for GO. For the quality and quantity limitation of the included studies, this conclusion needs to be proved by performing more high quality RCTs. Key words Graves ophthalmopathy; Somatostatin analogs; CAS; Proptosis; Meta-analysis Graves Graves ophthalmopathy GO DOI: / Graves shishaomin@foxmail.com * mr.heyebing@163.com Graves [1] Editorial Board of Chin J Evid-based Med
2 2013, 13(1): GO GO [2] GO GO [3] [4,5] GO GO RCT GO GO clinical active score CAS Mouritis GO CAS [6] NOSPES no sigh or symptoms only sighs soft tissue involvement proptosis extraocular muscle involment cornea involvement sight loss 1.2 PubMed EMbase The Cochrane Library WanFang Data CNKI VIP CBM 2013 Graves RCT Graves ophthalmopathy Graves obitorpathy thyroid associated ophthalmopathy thyroid eye disease endocrine ophthalmopathy endocrine eye and somatostatin ananlogue octreotide lanreotide SOM230 Graves SOM Cochrane RCT / 1.4 RevMan 5.0 Meta χ 2 P>0.10 I 2 <50% Meta P<0.10 I 2 50% Meta CAS MD 95%CI OR 95%CI RCT [5-9]
3 Review Articles Cochrane RCT [10] 5 RCT Meta CAS 4 [6-9] GO CAS P=0.37 I 2 =4% Meta CAS MD= %CI P= [6-8] GO P=0.56 I 2 =0% Meta GO MD= %CI P= [5-9] GO P=0.06 I 2 =55% Chin J Evid-based Med 2013, 13(1): Meta GO OR= %CI P= Chang [7] n=671 n=296 n=25 n=16 n=5 Meta n=5 1 n=0 n=9 n=11 1 % T/C Krassas 1995 [5] /8 100 μg ih.tid 3 Wemeau 2005 [6] /25 30 mg im Chang 2006 [7] Stan 2006 [8] /11 20 mg im. 1 4 tid 30 mg im NOSPECS NOSPECS CAS 30/30 30 mg 30 mg CAS im. 1 im mg CAS im Dickinson 2004 [9] /27 30 mg 30 mg CAS im. 4 1 im GO CAS Krassas 1995 [5] Wemeau 2005 [6] Chang 2006 [7] Stan 2006 [8] Dickinson 2004 [9] Editorial Board of Chin J Evid-based Med
4 2013, 13(1): GO Stan [8] 2 [7,8] Stan [8] GO 3 [5,6,9] [8] [11] Wemeau [6] Krassas [5] GO OR= %CI P= GO CAS Meta 3 GO Meta 4 GO Meta
5 Review Articles 3.1 GO Meta GO CAS CAS mm GO 2 [7,8] GO GO GO 3.2 GO GO IGF-1 IGF-1 [6] SstR SstR 1 5 SOM 230 [6,12,13] 3.3 [14] GO 3 5 [14] 3 Krassas [5,11,15] GO 110 Chin J Evid-based Med 2013, 13(1): CAS MD CAS CAS Wemeau [6] 2 mm 4 26 vs Stan [8] 2 mm 4 14 vs GO 3 [11,15,16] Wemeau [6] RCT 1 Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. European Journal of Endocrinology, 2008, 158: Bartalena L, Marcocci C, Tanda ML, et al. An update on medical management of Graves' ophthalmopathy. J Endocrinol Invest, 2005, 28: Bartalena L, Marcocci C, Pinchera A. Editorial: Somatostatin analogs for Graves' ophthalmopathy - Do they bounce off like a rubber bullet? J Clin Endocrinol Metab, 2004, 89(12): Kung AW, Michon J, Tai KS, et al. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Thyroid, 1996, 6(5): Krassas GE, Dumas A, Pontikides N, et al. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol, 1995, 42: Wemeau JL, Caron P, Beckers A, et al. Octreotide (long-acting release formulation) treatment in patients with Graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study. J Clin Endocrinol Metab, 2005, 90(2): Chang TC, Liao SL. Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial. J Endocrinol Invest, 2006, 29: Stan MN, Garrity JA, Bradley EA, et al. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J Clin Endocrinol Metab, 2006, 91(12): Dickinson AJ, Vaidya B, Miller M, et al. Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroidassociated ophthalmopathy. J Clin Endocrinol Metab, 2004, 89(12): Julian PT, Sally G (editors). Cochrane Handbook for Systematic Reviews of Interventions Version [updated March 2011]. Available from: 11 Krassas GE, Kaltsas T, Dumad A, et al. Lanreotide in the treatment of patients with thyroid eye disease. European journal of endocrinol Editorial Board of Chin J Evid-based Med
6 2013, 13(1): ogy, 1997, 136: Cozma I, Zhang L, Uddin J, et al. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs. Am J Physiol Endocrinol Metab, 2007, 293: E1630-E ,.., 2011, 35(5): Graves Meta., 2004, 25(4): Krassas GE, Doumas A, Kaltsas T, et al. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease. Thyroid, 1999, 9(1): Pichler R, Maschek W, Holzinger C. Therapy with somatostatin analogs in patient with orbitopathy and positive Octreoscan. Acta Med Austriaca, 2001, 28:
Double-Blind, Placebo-Controlled Trial of Octreotide Long-Acting Repeatable (LAR) in Thyroid-Associated Ophthalmopathy
0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(12):5910 5915 Printed in U.S.A. Copyright 2004 by The Endocrine Society doi: 10.1210/jc.2004-0697 Double-Blind, Placebo-Controlled
More informationCLINICAL ASSESSMENT OF PATIENTS WITH GRAVES ORBITOPATHY
44 MEDICINSKI GLASNIK / str. 44-48 Biljana Nedeljković-Beleslin 1 CLINICAL ASSESSMENT OF PATIENTS WITH GRAVES ORBITOPATHY Abstract: Clinical examination is the basis of a good assessment of a patient with
More informationThis slide kit covers more complex thyroid eye disease.
An imbalance in the normal level of thyroid hormone in the body can cause thyroid eye disease. If you wish to explore information on the basics of thyroid eye diseases, please first see: https://www.excemed.org/manage-thyroid-online/resources/thyroid-eyedisease
More informationResearch Article Corticosteroids for Graves Ophthalmopathy: Systematic Review and Meta-Analysis
BioMed Research International, Article ID 4845894, 9 pages https://doi.org/10.1155/2018/4845894 Research Article Corticosteroids for Graves Ophthalmopathy: Systematic Review and Meta-Analysis Xiaofang
More informationSerum Interleukin Profile in Patients with Graves Orbithopathy
Acta Medica Marisiensis 2013;59(1):31-35 DOI: 10.2478/amma-2013-0007 RESEARCH ARTICLE Serum Interleukin Profile in Patients with Graves Orbithopathy Réti Zsuzsánna, Kun IZ, Radu Pop Corina Cristina University
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of
More informationGRAVES ORBITOPATHY (GO) is diagnosed in 10 25%
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):841 848 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-1334 Octreotide (Long-Acting Release
More informationOriginal Article Efficacy of 99m Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves ophthalmopathy
Am J Nucl Med Mol Imaging 2012;2(2):242-247 www.ajnmmi.us /ISSN:2160-8407/ajnmmi1203001 Original Article Efficacy of 99m Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves ophthalmopathy Rong Zhao 1, Jiang
More informationThe patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey
European Journal of Endocrinology (2009) 161 483 487 ISSN 0804-4643 CLINICAL STUDY The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey Stephanie
More informationQUALITY OF LIFE IN GRAVES ORBITOPATHY
Jasmina Ćirić 1 QUALITY OF LIFE IN GRAVES ORBITOPATHY Abstract: The quality of life of patients with Graves orbitopathy (GO) may be seriously damaged due to the changes in appearance, working abilities
More informationManagement of Graves Orbitopathy
Management of Graves Orbitopathy Mario Salvi Graves Orbitopathy Center, Endocrinology Fondazione Ca Granda IRCCS, Milan, Dept. of Clinical and Community Sciences University of Milan, Italy Clinical course
More informationSUMMARY OF RANDOMIZED CONTROLLED TRIALS COMPARING DIFFERENT ORBITAL RADIOTHERAPY REGIMENTS AND ORBITAL RADIOTHERAPY TO PLACEBO OR CORTICOSTEROIDS
TABLE e4. SUMMARY OF RANDOMIZED CONTROLLED TRIALS COMPARING DIFFERENT ORBITAL RADIOTHERAPY REGIMENTS AND ORBITAL RADIOTHERAPY TO PLACEBO OR CORTICOSTEROIDS Study Treatment Groups Primary Outcome Measure
More informationOrbital and Ocular Adnexal Disorders with Red Eyes
Orbital and Ocular Adnexal Disorders with Red Eyes Jason Lee Associate Consultant Department of Ophthalmology and Visual Sciences Practical Ophthalmology for the Family Physician 21 Jan 2017 No financial
More informationAssessment of Quality of Life and Depression in Korean Patients with Graves Ophthalmopathy
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(2):65-72 DOI: 10.3341/kjo.2010.24.2.65 Assessment of Quality of Life and Depression in Korean Patients with Graves Ophthalmopathy Original
More informationRisk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean Patients
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(5):267-273 DOI: 10.3341/kjo.2010.24.5.267 Risk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean Patients Original
More informationEfficacy and safety of combined parenteral and oral steroid therapy in Graves orbitopathy
HORMONES 2014, 13(2):222-228 Research paper Efficacy and safety of combined parenteral and oral steroid therapy in Graves orbitopathy Biljana Nedeljkovic Beleslin, 1,2 Jasmina Ciric, 1,2 Milos Zarkovic,
More informationCVC site and the prevention of venous thrombosis, stenosis and infection? 1
infection? 1 Intravenous literature: Ge, X., Cavallazzi, R., Li, C., Pan, S.M., Wang, Y.W. and Wang, F.L. (2012) Central venous access sites for the prevention of venous thrombosis, stenosis and infection.
More informationGrave s orbitopathy an approach to clinical evaluation and management
Grave s orbitopathy an approach to clinical evaluation and management T W N Karunasena 1, M W S Niranjala 2 Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2012; 2: 106-110 Abstract Grave s
More informationWang et al. BMC Endocrine Disorders (2018) 18:13
Wang et al. BMC Endocrine Disorders (2018) 18:13 https://doi.org/10.1186/s12902-018-0240-8 RESEARCH ARTICLE Open Access A single-center retrospective study of factors related to the effects of intravenous
More informationMeta-Analysis of Randomized Controlled Trial in Treating Primary Liver Cancer by Fufang Kushen Injection Combined with TACE
4th International Conference on Sustainable Energy and Environmental Engineering (ICSEEE 2015) Meta-Analysis of Randomized Controlled Trial in Treating Primary Liver Cancer by Fufang Kushen Injection Combined
More informationPrevalence of Graves ophthalmopathy in patients with Graves disease presenting to a referral centre in north India
Indian J Med Res 139, January 2014, pp 99-104 Prevalence of Graves ophthalmopathy in patients with Graves disease presenting to a referral centre in north India Sagili Vijaya Bhaskar Reddy, Anu Jain *,
More information10 Congresso Nazionale Associazione Italiana della Tiroide Cagliari, dicembre 2016 Orbitopa)a basedowiana acuta
10 Congresso Nazionale Associazione Italiana della Tiroide Cagliari, 15-17 dicembre 2016 Orbitopa)a basedowiana acuta Luigi Bartalena Università dell Insubria a Varese Prevalence of Graves orbitopathy
More informationThyroid eye disease: a review
CLINICAL AND EXPERIMENTAL REVIEW Thyroid eye disease: a review Clin Exp Optom 2017; 100: 20 25 Danielle L Weiler* OD FAAO *Optometry Section, Southern Arizona Veterans Affairs Health Care System, Tucson,
More informationPENG Qin, TANG Shao-hui *, SHI Heng
504 2016 6 1 41 6 Meta [ ] (CHC) PubMed EMBASE The Cochrane Central Register of Controlled Trials CNKI CHC (RCTs) 2015 10 1 RevMan 5.3 Meta 6 RCT 1100 Meta(RVR) (cevr) (SVR 24 ) (P 0.0001) (60mg/d) RVR
More informationPasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line
Pasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line December 2010 This technology summary is based on information available at the time of research and a limited literature
More informationNovel Approaches to the Management of Graves' Ophthalmopathy
76 HORMONES L. BARTALENA 2002, 1(2):76-90 ET AL Review Novel Approaches to the Management of Graves' Ophthalmopathy Luigi Bartalena 1, Maria Laura Tanda 1, Alessandra Medea 1, Claudio Marcocci 2, Aldo
More informationRoshan S Prabhu 1,2*, Lang Liebman 4, Ted Wojno 3, Brent Hayek 3, William A Hall 1,2 and Ian Crocker 1,2
Prabhu et al. Radiation Oncology 2012, 7:95 RESEARCH Open Access Clinical outcomes of radiotherapy as initial local therapy for Graves ophthalmopathy and predictors of the need for post-radiotherapy decompressive
More informationA questionnaire survey on the management of Graves orbitopathy in Europe
European Journal of Endocrinology (2006) 155 207 211 ISSN 0804-4643 CLINICAL STUDY A questionnaire survey on the management of Graves orbitopathy in Europe The European Group of Graves Orbitopathy: P Perros,
More informationA systematic review of evidence-based guidelines for drug therapies for viral encephalitis in children
DOI:10.16636/j.cnki.jinn.2015.06.007 2 015 4 2 6 1 1 1 2 1 1. 530021 2. 530021 PubMed EMbase CBM CNKI NGC GIN TRIP CDC IDSA AAP WHO 2014 10 2 Ⅱ AGREEⅡ ICC 3 5 B AGREEⅡ6 68. 54 % Ⅱ A systematic review of
More informationClinical Study The Influence of Prior Hyperthyroidism on Euthyroid Graves Ophthalmopathy
Ophthalmology, Article ID 426898, 6 pages http://dx.doi.org/10.1155/2014/426898 Clinical Study The Influence of Prior Hyperthyroidism on Euthyroid Graves Ophthalmopathy Karolien Termote, 1 Brigitte Decallonne,
More informationORIGINAL ARTICLE. CM Ng HKL Yuen KL Choi MK Chan KT Yuen YW Ng SC Tiu
Key words: Eye diseases; Graves disease; Orbit/radiation effects; Steroids; Treatment outcome "#$% =L=" CM Ng HKL Yuen KL Choi MK Chan KT Yuen YW Ng SC Tiu Hong Kong Med J 2005;11:322-30 Queen Elizabeth
More informationJames A. Garrity MD Department of Ophthalmology. Marius N. Stan MD Division of Endocrinology. Mayo Clinic Rochester, MN
James A. Garrity MD Department of Ophthalmology Marius N. Stan MD Division of Endocrinology Mayo Clinic Rochester, MN Epidemiologic and diagnostic considerations for Graves orbitopathy (GO) 1. How common?
More informationGraves orbitopathy (GO), the main extrathyroidal
ORIGINAL ARTICLE Endocrine Care Prevalence and Natural History of Graves Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves Hyperthyroidism Seen at a Single Center M. L. Tanda, E. Piantanida,
More informationThyroid orbitopathy. Thyroid orbitopathy (TO) is an organ. CLINICAL PRACTICE: Therapeutic review
CLINICAL PRACTICE: Therapeutic review Thyroid orbitopathy Shirley Fung, MBBS, is a research resident, Oculoplastic and Orbital Unit, Department of Ophthalmology, Royal Adelaide Hospital, University of
More information7 Case reports Case series. 2 open label studies 131, Case reports
TABLE e5. ALTERNATIVE TREATMENTS FOR ACTIVE THYROID EYE DISEASE (TED) Pharmacological Agent/Intervention Classification of Treatment/Mechanism of Action Study Design(s) Results of Randomized Study (if
More informationPrevalence and Severity of Ophthalmic Manifestations of Graves Disease in Mashhad. University Endocrine Clinics
Prevalence and Severity of Ophthalmic Manifestations of Graves Disease in Mashhad University Endocrine Clinics Mohammad Etezad-Razavi, MD, 1 Robabeh-Beygom Aboutorabi, MD 2 Siamak Zarei-Ghanavati, MD,
More information*Please see amendment for Pennsylvania Medicaid at the
1 of 28 Number: 0419 Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB. I. Aetna considers orbital decompression surgery, and eye muscle surgery or eyelid surgery (e.g., marginal
More informationCLINICAL REVIEW. Thyroid eye disease. Petros Perros, 1 Christopher Neoh, 2 Jane Dickinson 2. For the full versions of these articles see bmj.
For the full versions of these articles see bmj.com CLINICAL REVIEW Thyroid eye disease Petros Perros, 1 Christopher Neoh, 2 Jane Dickinson 2 1 Department of Endocrinology, Royal Victoria Infirmary, Newcastle
More informationAzienda Ospedaliera-Universitaria Mater Domini, Catanzaro, Italy
Article 1 Subclinical Visual Field Alterations are Commonly Present in Patients with Graves Orbitopathy and are Mainly Related to the Clinical Activity of the Disease Authors A. F. L a bo nia 1, G. C.
More informationSetting: The study was conducted at the University Hospital Thyroid-Eye Clinic.
ORIGINAL ARTICLE Double Vision Is a Major Manifestation in Moderate to Severe Graves Orbitopathy, but It Correlates Negatively With Inflammatory Signs and Proptosis Peter Laurberg, Dalia C. Berman, Inge
More informationResearch Article A Meta-Analysis of Randomized Controlled Trials on Acupuncture for Amblyopia
Evidence-Based Complementary and Alternative Medicine Volume 2013, Article ID 648054, 6 pages http://dx.doi.org/10.1155/2013/648054 Research Article A Meta-Analysis of Randomized Controlled Trials on Acupuncture
More informationPharmacy Prior Authorization Somatostatin Analogs Clinical Guideline
Sandostatin LAR (octreotide) Signifor (pasireotide) Signifor LAR (pasireotide) Somatuline Depot (lanreotide) octreotide FDA Approved Indications: Acromegaly: Octreotide Injection is indicated to reduce
More information(The CHBG) Dimitrinka Nikolova, Managing Editor, Editorial Team Office, The Cochrane Hepato-Biliary Group
The Cochrane Hepato-Biliary Group (The CHBG) Dimitrinka Nikolova, Managing Editor, Editorial Team Office, The Cochrane Hepato-Biliary Group Copenhagen Trial Unit, Rigshopitalet, Copenhagen, Denmark dimitrinka.nikolova@ctu.dk
More information! Women greater than men (4:1)» Typical of other autoimmune diseases
1 2 3 4 : Overview and Diagnosis Suzanne K. Freitag, M.D. Director, Ophthalmic Plastic Surgery Massachusetts Eye and Ear Infirmary Harvard Medical School! I have no financial disclosures. Learning Objectives!
More informationCell Physiol Biochem 2016;39: DOI: / Huang et al.: Clinical Effects of Aspirin in Combination with FDD
Original Paper 2016 The Author(s). 2016 Published The Author(s) by S. Karger AG, Basel Published online: October 24, 24, 2016 2016 Published by S. Karger AG, Basel 1955 Accepted: August 17, 2016 This article
More informationResearch Article The Influence of Juvenile Graves Ophthalmopathy on Graves Disease Course
Hindawi Ophthalmology Volume 2017, Article ID 4853905, 5 pages https://doi.org/10.1155/2017/4853905 Research Article The Influence of Juvenile Graves Ophthalmopathy on Graves Disease Course Jurate Jankauskiene
More informationClinical Study Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves Orbitopathy
International Endocrinology Volume 2015, Article ID 285698, 8 pages http://dx.doi.org/10.1155/2015/285698 Clinical Study Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Smith TJ, Kahaly GJ, Ezra DG, et al. Teprotumumab for thyroid-associated
More informationReliability of Echocardiography Measurement of Patent Ductus Arteriosus Minimum Diameter: A Meta-analysis
International Journal of Cardiovascular and Cerebrovascular Disease 4(): 15-19, 016 DOI: 10.13189/ijccd.016.04001 http://www.hrpub.org Reliability of Echocardiography Measurement of Patent Ductus Arteriosus
More informationGraves Ophthalmopathy: The Role of Thyroid Cross Reacting Autoantigens and The Effect of Thyroid Ablation
Int J Endocrinol Metab 2006; 4: 47-51 Graves Ophthalmopathy: The Role of Thyroid Cross Reacting Autoantigens and The Effect of Thyroid Ablation Latrofa F, Marino M, Marcocci C, Pinchera A. Department of
More informationAcupuncture combined with herbal medicine versus herbal medicine alone for plaque psoriasis: a systematic review protocol
Study Protocol Page 1 of 6 Acupuncture combined with herbal medicine versus herbal medicine alone for plaque psoriasis: a systematic review protocol Shiju Xiao 1,2, Bo Li 3, Shuo Feng 3, Cunzhi Liu 4,
More informationSelenium and the Course of Mild Graves Orbitopathy
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article and the Course of Mild Graves Orbitopathy Claudio Marcocci, M.D., George J. Kahaly, M.D., Gerasimos E. Krassas, M.D., Luigi Bartalena,
More informationManagement of patients with Graves orbitopathy: initial assessment, management outside specialised centres and referral pathways
Clinical Medicine 2015 Vol 15, No 2: 173 8 CONCISE GUIDANCE Management of patients with Graves orbitopathy: initial assessment, management outside specialised centres and referral pathways Authors: Petros
More informationSystematic review: The effectiveness and safety of diclofenac for the. pain management after cesarean
Systematic review: The effectiveness and safety of diclofenac for the pain management after cesarean ABSTRACT This is the protocol of systematic review and there is no abstract. The objective is to evaluate
More informationGraves' disease (GD) is the most common cause
Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy Jung Hyun Lee, So Hyun Park, Dae Gyun Koh, Byung Kyu Suh Gyeonggi-do, Korea Background:
More informationAdvances In The Management of Thyroid Eye Diseases -An Overview
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 4 Ver. III (April. 2017), PP 114-120 www.iosrjournals.org Advances In The Management of Thyroid
More informationThe treatment of thyroid-associated. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroidassociated
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroidassociated ophthalmopathy Ritva Kauppinen-Mäkelin 1, Anni Karma 2, Eeva Leinonen 1, Eliisa Löyttyniemi 3, Oili Salonen
More informationReview Article Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
Clinical and Developmental Immunology Volume 2013, Article ID 310628, 16 pages http://dx.doi.org/10.1155/2013/310628 Review Article Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
More informationAmerican Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More informationTreatment of Graves' ophthalmopathy with an in house Phosphorus 32 source: Initial clinical observations
EXPERIMENTAL AND THERAPEUTIC MEDICINE 14: 2795-2800, 2017 Treatment of Graves' ophthalmopathy with an in house Phosphorus source: Initial clinical observations HAI TAO HAO 1, YUJUN WANG 2, XUFU WANG 3,
More informationWiersinga WM, Kahaly GJ (eds): Graves Orbitopathy: A Multidisciplinary Approach Questions and Answers. Basel, Karger, 2010, pp 33 39
Diagnosis and Pathogenesis Wiersinga WM, Kahaly GJ (eds): Graves Orbitopathy: A Multidisciplinary Approach Questions and Answers. Basel, Karger, 2010, pp 33 39 Epidemiology C. Daumerie Department of Endocrinology,
More information5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA
5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA Background RCTs investigating the efficacy of aminosalicylates for
More informationEffectiveness of Balance Acupuncture for the Pain in. Neck-Shoulder-Low back-legs: A Meta-Analysis
Hou-Lian WANG et al./journal of Acupuncture and Herbs 1 (201)9-1 9 Effectiveness of Balance Acupuncture for the Pain in Neck-Shoulder-Low back-legs: A Meta-Analysis Hou-Lian WANG a, An-Lin GUO a, Jun-Yun
More informationUpdate on advanced imaging options for thyroid-associated orbitopathy
Saudi Journal of Ophthalmology (2012) 26, 385 392 Oculoplastic Imaging Update Update on advanced imaging options for thyroid-associated orbitopathy Michael P. Rabinowitz, MD; Jacqueline R. Carrasco, MD
More informationOriginal Article Randomized and controlled trials of Sanren Decoction s treatment on upper respiratory infections: a meta-analysis
Int J Clin Exp Med 2016;9(7):12954-12958 www.ijcem.com /ISSN:1940-5901/IJCEM0021100 Original Article Randomized and controlled trials of Sanren Decoction s treatment on upper respiratory infections: a
More informationClinical Policy: Pasireotide (Signifor LAR) Reference Number: CP.PHAR.332
Clinical Policy: (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: 03/17 Last Review Date: 02/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationCritical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search
Adv Ther (2015) 32:595 611 DOI 10.1007/s12325-015-0228-y REVIEW Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search Konstadinos G. Boboridis.
More informationClinical Study Methotrexate for the Treatment of Thyroid Eye Disease
Ophthalmology, Article ID 128903, 5 pages http://dx.doi.org/10.1155/2014/128903 Clinical Study Methotrexate for the Treatment of Thyroid Eye Disease Diego Strianese, 1 Adriana Iuliano, 1 Mariantonia Ferrara,
More informationZHANG Qin, YANG Yun-mei, LV Xue-ying
Zhang et al. / J Zhejiang Univ SCIENCE B 2006 7(11):887-891 887 Journal of Zhejiang University SCIENCE B ISSN 1673-1581 (Print); ISSN 1862-1783 (Online) www.zju.edu.cn/jzus; www.springerlink.com E-mail:
More informationOriginal Article Prophylactic treatment of the recurrence of febrile convulsion by different drugs: a meta-analysis
Int J Clin Exp Med 2017;10(4):6453-6460 www.ijcem.com /ISSN:1940-5901/IJCEM0045956 Original Article Prophylactic treatment of the recurrence of febrile convulsion by different drugs: a meta-analysis Xiaoqiao
More informationOxidative stress markers in tears of patients with Graves orbitopathy and their correlation with clinical activity score
Choi et al. BMC Ophthalmology (2018) 18:303 https://doi.org/10.1186/s12886-018-0969-x RESEARCH ARTICLE Open Access Oxidative stress markers in tears of patients with Graves orbitopathy and their correlation
More informationNOTE. Endocrinol. Japon. 1982, 29 (4), Abstract
Endocrinol. Japon. 1982, 29 (4), 495-501 NOTE Treatment of Graves' Ophthalmopathy by Steroid Therapy, Orbital Radiation Therapy, Plasmapheresis and Thyroxine Replacement KUNIHIRO YAMAMOTO, KOSHI SAITO,
More informationRituximab for thyroid-associated ophthalmopathy (Review)
Minakaran N, Ezra DG This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 6 http://www.thecochranelibrary.com
More informationSystematic review of the effects of iodised salt and iodised oil on prenatal and postnatal growth
Grant proposal to Japan Foundation for Growth Science, October 28, 2013 Systematic review of the effects of iodised salt and iodised oil on prenatal and postnatal growth Principal Investigator Prof. Michael
More informationEuthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy
1 Department of Ophthalmology, University of Essen, Essen, Germany; 2 Institute for Medical Informatics, Biometry and Epidemiology University of Essen, Essen, Germany; 3 Department of Medicine, Division
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: somatostatin_analogs 7/2016 7/2017 7/2018 7/2017 Description of Procedure or Service Somatostatin, a hypothalamic
More informationCutting Edge Treatment of Neuroendocrine Tumors
Cutting Edge Treatment of Neuroendocrine Tumors Daneng Li, MD Assistant Clinical Professor Department of Medical Oncology & Therapeutics Research City of Hope Click to edit Master Presentation Date DISCLOSURE
More informationSystematic Review Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: a meta-analysis
Journal homepage: www.jcimjournal.com/jim www.elsevier.com/locate/issn/20954964 Available also online at www.sciencedirect.com. Copyright 2017, Editorial Office. E-edition published by Elsevier (Singapore)
More informationOriginal 2016, 63 (2), Ito Hospital, Tokyo, Japan 2) Olympia Eye Hospital, Tokyo, Japan
2016, 63 (2), 151-157 Original TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves ophthalmopathy in untreated Japanese Graves disease patients Koji
More informationCutting Edge Treatment of Neuroendocrine Tumors
Cutting Edge Treatment of Neuroendocrine Tumors Daneng Li, MD Assistant Clinical Professor Department of Medical Oncology & Therapeutics Research City of Hope Click to edit Master Presentation Date DISCLOSURE
More informationThe role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves ophthalmopathy
ORIGINAL ARTICLE Annals of Nuclear Medicine Vol. 16, No. 7, 461 465, 2002 The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves ophthalmopathy Hulya ORTAPAMUK,* Banu HOSAL** ç and
More informationReview Article Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails
Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 468520, 13 pages http://dx.doi.org/10.1155/2015/468520 Review Article Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia:
More informationClinical Policy: Pasireotide (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: 03.01.17 Last Review Date: 11.17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the
More informationDrain versus no-drain after gastrectomy for patients with advanced gastric cancer Student EBM presentations
Drain versus no-drain after gastrectomy for patients with advanced gastric cancer Student EBM presentations Selali Fiamanya & Jawaad Farrukh University of Oxford October 2014 The question Mr X is a 56
More informationCochrane Breast Cancer Group
Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.
More informationGraves ophthalmopathy: a preventable disease?
European Journal of Endocrinology (2002) 146 457 461 ISSN 0804-4643 MINI REVIEW Graves ophthalmopathy: a preventable disease? Luigi Bartalena, Claudio Marcocci 1 and Aldo Pinchera 1 Cattedra di Endocrinologia,
More informationReview Article An Overview of Systematic Reviews of Danhong Injection for Ischemic Stroke
Evidence-Based Complementary and Alternative Medicine Volume 2016, Article ID 8949835, 7 pages http://dx.doi.org/10.1155/2016/8949835 Review Article An Overview of Systematic Reviews of Danhong Injection
More informationSix Things That Changed How I Manage Graves Disease
Six Things That Changed How I Manage Graves Disease Anthony DeWilde, OD FAAO Kansas City VAMC 6 Things 1. Thyroid status 2. Pathogenesis 3. Ocular signs/symptoms 4. Labs 5. Smoking 6. Mental Health Graves
More informationExophthalmos in a young woman with no Graves disease a case report of IgG4- related orbitopathy
Erdei et al. BMC Ophthalmology (2018) 18:5 DOI 10.1186/s12886-018-0672-y CASE REPORT Open Access Exophthalmos in a young woman with no Graves disease a case report of IgG4- related orbitopathy Annamaria
More informationEfficacy of 99m Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves disease
Szumowski et al. BMC Endocrine Disorders (2019) 19:10 https://doi.org/10.1186/s12902-019-0340-0 RESEARCH ARTICLE Efficacy of 99m Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves disease Open Access
More information- Meta. : (rfsh); (ufsh); (IVF); : R711.6 : A : X(2015) : hmg( FSH LH) [ufsh, (ufsh-p) (ufsh-hp)] (rfsh) [1] 80, rfsh, 90, :
35 2 Vol.35 No.2 2015 2 Feb. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.02.0099 E-mail: randc_journal@163.com (FSH) - Meta FSH ( 400010) : (IVF) (ICSI) (rfsh) (ufsh) (COS) : PubMed
More informationSupplementary Material. Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a
Supplementary Material Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials Xueqiang Wang a b, Yanling Pi c, Binglin Chen
More informationZheng-tao Lv, 1 Wen-xiu Jiang, 2 Jun-ming Huang, 1 Jin-ming Zhang, 1 and An-min Chen Introduction
Evidence-Based Complementary and Alternative Medicine Volume 2016, Article ID 8792167, pages http://dx.doi.org/.1155/2016/8792167 Research Article The Clinical Effect of Acupuncture in the Treatment of
More informationQuality of Life in Patients with Thyroid Eye Disease
Quality of Life in Patients with Thyroid Eye Disease Mohsen Bahmani-Kashkouli, MD; Farzad Pakdel, MD; Arezoo Astaraki, MD Masih Hashemi, MD; Yasamin Honarbakhsh, MD; Bahareh Mirarmandehi, MD; Sara Jam,
More informationGRAVES OPHTHALMOPAthy
CLINICAL SCIENCES Oxidative Stress Change by Systemic Corticosteroid Among Patients Having Active Graves Ophthalmopathy Chieh-Chih Tsai, MD; Shu-Ching Kao, MD; Ching-Yu Cheng, MD, MPH; Hui-Chuan Kau, MD,
More informationOriginal Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis
Int J Clin Exp Med 2015;8(6):9093-9099 www.ijcem.com /ISSN:1940-5901/IJCEM0008614 Original Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis Tao Fu 1*,
More informationDisappearance of a GH secreting macro adenoma, during long-term somatostatin analogue administration and recurrence following somatostatin withdrawal
HORMONES 2006, 5(1):57-62 Case report Disappearance of a GH secreting macro adenoma, during long-term somatostatin analogue administration and recurrence following somatostatin withdrawal S. Livadas 1,
More informationPrognostic value of serum CYFRA 21-1 and CEA for non- small- cell lung cancer
Cancer Medicine ORIGINAL RESEARCH Open Access Prognostic value of serum CYFRA 21-1 and CEA for non- small- cell lung cancer Zhi-Hui Zhang 1,a, Yun-Wei Han 2,a, Hui Liang 3 & Le-Min Wang 4 1 Department
More informationDepartment of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
C A S E REPORT pissn: 2384-3799 eissn: 2466-1899 Int J Thyroidol 2017 November 10(2): 102-106 https://doi.org/10.11106/ijt.2017.10.2.102 Development of Graves Ophthalmopathy after Radioactive Iodine Ablation
More informationEUGOGO FOLLOW-UP assessment
EUGOGO FOLLOW-UP assessment Please complete non-italicized boxes except where indicated, plus relevant italicized ones. F1. Date follow-up (dd mm yyyy) Visit # Year of birth ( yyyy ) Randomization code
More information